Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in Steroid-dependent Crohn's Disease
NCT04056442Phase 2Completed
- Sponsor
- STERO Biotechs
- Start
- Jul 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Crohn's disease, sponsored by STERO Biotechs. Started Jul 2019; status: completed.
02
Drugs
cannabidiol
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04056442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056442.